Acyclovir-Associated Liver Enzyme Elevation
Acyclovir can cause mild, transient elevations in liver function tests, but clinically apparent liver injury is rare. [1] Serum enzyme levels generally do not change during oral acyclovir therapy. [1] When liver test abnormalities occur, alternative causes (including the underlying illness) are common and should be assessed. [1]
Expected Pattern and Frequency
Liver enzyme elevations with acyclovir are described as minor and uncommon. [1] In pediatric cohorts receiving intravenous acyclovir for HSV encephalitis, elevated liver enzymes were reported in 6.5% (4 of 61). [1]
FDA Label Adverse-Effect Language
The acyclovir label lists hepatobiliary adverse events, including elevated liver function tests, hepatitis, and hyperbilirubinemia/jaundice. [2]
Clinical Apparent Drug-Induced Liver Injury
LiverTox reports that there have been no published reports of acyclovir causing clinically apparent liver injury. [1] Rare idiosyncratic severe hepatic injury has been reported in the context of serious HSV syndromes and complex patients, but causality to acyclovir versus disseminated HSV is difficult in those cases. [1]
Alternative Explanations in a Patient Not Receiving Immunotherapy
Underlying HSV infection (including disseminated disease) can be associated with hepatitis and liver test abnormalities. [1] Co-morbid illness, concurrent medications, and infection-related cholestasis or hepatic injury commonly contribute to abnormal liver tests during antiviral treatment. [1]
Practical Monitoring Considerations
Baseline liver tests should be checked in patients with pre-existing liver disease or severe systemic illness. [1] Repeat liver tests should be obtained when liver test elevations emerge during therapy. [1] Acyclovir should be discontinued and urgent evaluation considered when hepatitis is suspected clinically (for example, jaundice or significant transaminase elevations with systemic symptoms). [2]
Common Pitfalls to Avoid
Attribution to acyclovir should not be assumed based on a mild transaminase rise alone. [1] Failure to evaluate competing causes such as active HSV hepatitis or other concurrent etiologies can lead to misattribution. [1]
Severity Markers Requiring Urgent Evaluation
Clinically significant hepatitis should be suspected when bilirubin rises or jaundice develops during therapy. [2] Urgent reassessment is indicated when liver test abnormalities are accompanied by signs of systemic decompensation. [2]